NASDAQ:BIIB
Biogen Inc.
- Stock
Last Close
156.74
06/11 22:15
Market Cap
33.89B
Beta: 0.19
Volume Today
2.32M
Avg: 876.67K
PE Ratio
24.00
PFCF: 34.22
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 731.51M - | 848.71M 16.02% | 947.50M 11.64% | 952.15M 0.49% | 916.30M 3.77% | 867.05M 5.37% | 936.40M 8.00% | 1.21B 29.22% | 1.35B 11.40% | ||
average payables | 224.55M - | 248.29M 10.57% | 273.60M 10.19% | 337.65M 23.41% | 383M 13.43% | 450.65M 17.66% | 492.85M 9.36% | 522.05M 5.92% | 540.35M 3.51% | ||
average receivables | 1.06B - | 1.26B 19.02% | 1.33B 5.92% | 1.61B 20.98% | 1.87B 16.01% | 1.92B 2.50% | 1.90B 1.16% | 1.73B 8.73% | 1.84B 6.43% | ||
book value per share | 45.75 - | 40.64 11.18% | 55.53 36.66% | 59.26 6.70% | 63.60 7.33% | 71.29 12.10% | 66.41 6.84% | 73.51 10.68% | 92.14 25.36% | ||
capex per share | -1.22 - | -2.79 128.94% | -3.33 19.55% | -9.23 177.09% | -4.32 53.16% | -3.58 17.26% | -3.43 4.16% | -1.98 42.33% | -1.67 15.37% | ||
capex to depreciation | -0.42 - | -1.07 156.12% | -1.07 0.47% | -1.82 70.34% | -0.87 52.00% | -0.98 12.86% | -1.21 22.69% | -0.60 49.90% | -0.47 22.42% | ||
capex to operating cash flow | -0.10 - | -0.17 76.92% | -0.16 7.00% | -0.43 168.03% | -0.14 66.80% | -0.09 33.95% | -0.13 37.93% | -0.08 37.90% | -0.18 116.84% | ||
capex to revenue | -0.03 - | -0.06 101.44% | -0.06 6.40% | -0.16 151.59% | -0.07 58.81% | -0.05 29.31% | -0.04 11.86% | -0.03 34.57% | -0.02 10.98% | 0.03 217.81% | |
cash per share | 7.81 - | 14.86 90.35% | 22.41 50.82% | 17.35 22.58% | 17.27 0.49% | 23.92 38.54% | 16.22 32.19% | 25.50 57.21% | 33.67 32.04% | ||
days of inventory on hand | 250.61 - | 262.89 4.90% | 247.23 5.96% | 202.14 18.24% | 186.87 7.55% | 150.11 19.67% | 216.06 43.93% | 233.82 8.22% | 215.38 7.89% | ||
days payables outstanding | 71.43 - | 78.69 10.15% | 69.07 12.23% | 88.56 28.23% | 74.45 15.93% | 99.08 33.07% | 91.98 7.17% | 101.94 10.83% | 78.74 22.75% | ||
days sales outstanding | 48.62 - | 41.61 14.42% | 45.96 10.46% | 53.14 15.63% | 53.14 0.01% | 47.74 10.16% | 51.96 8.84% | 51.50 0.88% | 76.65 48.84% | ||
debt to assets | 0.04 - | 0.33 718.58% | 0.28 14.86% | 0.25 11.88% | 0.23 6.50% | 0.23 0.40% | 0.32 36.00% | 0.32 0.15% | 0.27 15.41% | ||
debt to equity | 0.05 - | 0.70 1,186.43% | 0.54 22.81% | 0.47 12.28% | 0.46 3.35% | 0.48 4.79% | 0.73 53.46% | 0.69 5.30% | 0.49 28.79% | ||
dividend yield | 0.68 - | 0.08 87.72% | 0.00 - | 0.00 83.24% | |||||||
earnings yield | 0.04 - | 0.05 37.20% | 0.06 19.13% | 0.04 37.29% | 0.07 91.68% | 0.11 47.60% | 0.10 4.26% | 0.04 57.16% | 0.08 74.08% | ||
enterprise value | 79.61B - | 75.89B 4.68% | 66.12B 12.87% | 72.09B 9.03% | 66.37B 7.93% | 58.97B 11.15% | 45.89B 22.17% | 41.11B 10.42% | 43.43B 5.64% | ||
enterprise value over ebitda | 18.30 - | 13.74 24.89% | 10.11 26.46% | 11.05 9.28% | 9.67 12.42% | 7.84 18.93% | 9.55 21.72% | 11.24 17.77% | 16.17 43.80% | ||
ev to operating cash flow | 27.06 - | 20.42 24.53% | 14.62 28.41% | 15.84 8.34% | 10.73 32.29% | 8.33 22.33% | 10.85 30.24% | 11.30 4.10% | 31.37 177.76% | ||
ev to sales | 8.20 - | 7.05 14.07% | 5.78 18.09% | 5.87 1.70% | 4.93 16.00% | 4.10 16.86% | 3.41 16.77% | 3.74 9.67% | 4.27 14.03% | ||
free cash flow per share | 11.23 - | 13.32 18.62% | 17.38 30.44% | 12.17 29.93% | 25.87 112.53% | 34.25 32.39% | 22.86 33.27% | 22.43 1.86% | 7.85 64.99% | ||
free cash flow yield | 0.03 - | 0.04 31.43% | 0.06 40.91% | 0.04 37.63% | 0.09 125.00% | 0.12 34.26% | 0.09 19.13% | 0.09 0.16% | 0.03 69.67% | ||
graham net net | -1.21 - | -23.12 1,812.35% | -19.56 15.42% | -26.22 34.06% | -33.12 26.31% | -40.66 22.77% | -58.13 42.98% | -48.81 16.04% | -27.52 43.62% | ||
graham number | 113.06 - | 118.57 4.87% | 145.55 22.76% | 126.19 13.30% | 175.91 39.40% | 224.69 27.73% | 192.76 14.21% | 131.38 31.84% | 208.51 58.70% | ||
income quality | 1.00 - | 1.03 3.40% | 1.22 18.32% | 1.70 39.29% | 1.38 18.86% | 1.20 13.08% | 1.04 13.34% | 2.11 102.26% | 0.47 77.82% | ||
intangibles to total assets | 0.40 - | 0.35 14.43% | 0.33 5.53% | 0.36 10.10% | 0.35 3.02% | 0.34 2.32% | 0.36 5.40% | 0.33 6.96% | 0.31 7.43% | 0 100% | |
interest coverage | 134.66 - | 51.21 61.97% | 19.81 61.32% | 21.31 7.57% | 29.35 37.76% | 37.58 28.02% | 20.45 45.58% | 11.20 45.22% | 9.41 16.00% | ||
interest debt per share | 2.60 - | 28.70 1,003.67% | 31.03 8.11% | 29.11 6.19% | 29.95 2.89% | 35.03 16.97% | 50.04 42.82% | 52.70 5.32% | 47.22 10.40% | ||
inventory turnover | 1.46 - | 1.39 4.67% | 1.48 6.33% | 1.81 22.31% | 1.95 8.17% | 2.43 24.49% | 1.69 30.52% | 1.56 7.60% | 1.69 8.56% | ||
invested capital | 0.05 - | 0.70 1,186.43% | 0.54 22.81% | 0.47 12.28% | 0.46 3.35% | 0.48 4.79% | 0.73 53.46% | 0.69 5.30% | 0.49 28.79% | ||
market cap | 80.23B - | 70.67B 11.91% | 61.93B 12.37% | 67.73B 9.36% | 61.66B 8.96% | 55.52B 9.96% | 39.40B 29.04% | 35.77B 9.20% | 40.24B 12.48% | ||
net current asset value | 1.17B - | -3.43B 393.09% | -2.02B 41.22% | -3.18B 57.80% | -4.62B 45.12% | -5.51B 19.43% | -7.05B 27.79% | -5.06B 28.17% | -1.37B 72.84% | ||
net debt to ebitda | -0.14 - | 0.94 762.91% | 0.64 32.23% | 0.67 4.42% | 0.69 2.78% | 0.46 33.12% | 1.35 194.21% | 1.46 8.10% | 1.19 18.59% | ||
net income per share | 12.42 - | 15.37 23.83% | 16.95 10.27% | 11.94 29.56% | 21.62 81.06% | 31.47 45.55% | 24.86 21.00% | 10.44 58.02% | 20.97 100.92% | ||
operating cash flow per share | 12.45 - | 16.11 29.41% | 20.71 28.55% | 21.41 3.38% | 30.20 41.07% | 37.83 25.28% | 26.29 30.52% | 24.41 7.14% | 9.53 60.97% | ||
payables turnover | 5.11 - | 4.64 9.22% | 5.28 13.93% | 4.12 22.02% | 4.90 18.95% | 3.68 24.85% | 3.97 7.72% | 3.58 9.77% | 4.64 29.46% | ||
receivables turnover | 7.51 - | 8.77 16.85% | 7.94 9.47% | 6.87 13.51% | 6.87 0.01% | 7.65 11.31% | 7.03 8.12% | 7.09 0.89% | 4.76 32.81% | ||
research and ddevelopement to revenue | 0.20 - | 0.19 4.17% | 0.17 7.83% | 0.18 6.53% | 0.19 5.15% | 0.16 17.84% | 0.30 87.14% | 0.23 23.27% | 0.22 3.71% | 0.25 14.14% | |
return on tangible assets | 0.34 - | 0.28 19.20% | 0.24 13.53% | 0.17 30.26% | 0.27 60.49% | 0.33 21.89% | 0.25 22.69% | 0.10 61.40% | 0.18 83.56% | ||
revenue per share | 41.05 - | 46.66 13.65% | 52.42 12.35% | 57.73 10.13% | 65.66 13.72% | 76.85 17.04% | 83.56 8.74% | 73.65 11.85% | 70.02 4.94% | ||
roe | 0.27 - | 0.38 39.41% | 0.31 19.31% | 0.20 33.98% | 0.34 68.69% | 0.44 29.84% | 0.37 15.19% | 0.14 62.07% | 0.23 60.28% | ||
roic | 0.26 - | 0.23 10.89% | 0.21 11.05% | 0.15 27.47% | 0.24 56.85% | 0.29 24.52% | 0.19 34.08% | 0.15 24.54% | 0.09 35.54% | ||
sales general and administrative to revenue | |||||||||||
shareholders equity per share | 45.75 - | 40.64 11.18% | 55.53 36.66% | 59.26 6.70% | 63.60 7.33% | 71.29 12.10% | 66.41 6.84% | 73.51 10.68% | 92.14 25.36% | ||
stock based compensation to revenue | 0.02 - | 0.01 6.31% | 0.01 9.83% | 0.01 22.87% | 0.01 12.26% | 0.01 8.30% | 0.01 16.33% | 0.02 47.31% | 0.02 14.96% | ||
tangible asset value | 5.03B - | 2.63B 47.74% | 4.65B 77.11% | 4.09B 12.15% | 4.21B 2.92% | 4.05B 3.60% | 1.84B 54.62% | 2.98B 61.84% | 5.79B 94.45% | ||
tangible book value per share | 21.26 - | 11.38 46.46% | 21.30 87.09% | 19.22 9.75% | 20.52 6.78% | 21.67 5.57% | 11.43 47.23% | 19.97 74.64% | 39.84 99.53% | ||
working capital | 2.45B - | 4.12B 68.07% | 5.40B 30.87% | 4.51B 16.50% | 4.35B 3.54% | 3.52B 19.05% | 3.14B 10.61% | 3.56B 13.15% | 6.52B 83.19% |
All numbers in USD (except ratios and percentages)